282
Views
29
CrossRef citations to date
0
Altmetric
Review

Early Diagnosis And Management Of Malignant Distal Biliary Obstruction: A Review On Current Recommendations And Guidelines

&
Pages 415-432 | Published online: 05 Nov 2019

References

  • Boulay BR, Birg A. Malignant biliary obstruction: from palliation to treatment. World J Gastrointest Oncol. 2016;8(6):498–508. doi:10.4251/wjgo.v8.i6.49827326319
  • Fogel EL, Shahda S, Sandrasegaran K, et al. A multidisciplinary approach to pancreas cancer in 2016: a review. Am J Gastroenterol. 2017;112(4):537–554. doi:10.1038/ajg.2016.61028139655
  • Pu LZCT, Singh R, Loong CK, de Moura EGH. Malignant biliary obstruction: evidence for best practice. Gastroenterol Res Pract. 2016;2016:1–7. doi:10.1155/2016/3296801
  • Singh A, Gelrud A, Agarwal B. Biliary strictures: diagnostic considerations and approach. Gastroenterol Rep. 2015;3(1):22–31. doi:10.1093/gastro/gou072
  • Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected Burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921. doi:10.1158/0008-5472.CAN-14-015524840647
  • Hidalgo M. Pancreatic Cancer. N Engl J Med. 2010;362(17):1605–1617. doi:10.1056/NEJMra090155720427809
  • Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15(2):95–111. doi:10.1038/nrclinonc.2017.15728994423
  • Choi BI, Han JK, Hong ST, Lee KH. Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis. Clin Microbiol Rev. 2004;17(3):540–552. doi:10.1128/CMR.17.3.540-552.200415258092
  • Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24(2):115–125. doi:10.1055/s-2004-82888915192785
  • Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99–109. doi:10.2147/CLEP.S3735724634588
  • Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol. 2017;23(22):3978–3998. doi:10.3748/wjg.v23.i22.397828652652
  • Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98(7):485–489. doi:10.1002/jso.v98:718802958
  • Ahn DH, Bekaii-Saab T. Ampullary cancer: an overview HHS public access. Am Soc Clin Oncol Educ B. 2014;112–115. doi:10.14694/EdBook_AM.2014.34.112
  • Porta M, Fabregat X, Malats N, et al. Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. Clin Transl Oncol. 2005;7(5):189–197. doi:10.1007/BF0271281615960930
  • Furukawa H, Okada S, Saisho H, et al. Clinicopathologic features of small pancreatic adenocarcinoma. A collective study. Cancer. 1996;78(5):986–990. doi:10.1002/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A8780535
  • Khan SA, Davidson BR, Goldin RD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61(12):1657–1669. doi:10.1136/gutjnl-2011-30174822895392
  • Garcea G, Ngu W, Neal CP, Dennison AR, Berry DP. Bilirubin levels predict malignancy in patients with obstructive jaundice. HPB. 2011;13(6):426–430. doi:10.1111/j.1477-2574.2011.00312.x21609376
  • Thomasset SC, Saunders D, Holland A, Dennison AR, Garcea G. Malignant biliary strictures in patients with a normal bilirubin and/or normal liver enzymes. HPB (Oxford). 2015;17(11):969–974. doi:10.1111/hpb.1246826256123
  • Kim HJ, Kim MH, Myung SJ, et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol. 1999;94(7):1941–1946. doi:10.1111/j.1572-0241.1999.01234.x10406263
  • Nehls O, Gregor M, Serum KB. Bile Markers for Cholangiocarcinoma. Semin Liver Dis. 2004;24(02):139–154. doi:10.1055/s-2004-82889115192787
  • Marrelli D, Caruso S, Pedrazzani C, et al. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions. Am J Surg. 2009;198(3):333–339. doi:10.1016/j.amjsurg.2008.12.03119375064
  • Hasan S, Jacob R, Manne U, Paluri R. Advances in pancreatic cancer biomarkers. Oncol Rev. 2019;13(1):410. doi:10.4081/oncol.2019.41031044028
  • Tsukada K, Takada T, Miyazaki M, et al. Diagnosis of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008;15(1):31–40. doi:10.1007/s00534-007-1278-618274842
  • Anderson MA, Appalaneni V, Ben-Menachem T, et al. The role of endoscopy in the evaluation and treatment of patients with biliary neoplasia. Gastrointest Endosc. 2013;77(2):167–174. doi:10.1016/j.gie.2012.09.02923219047
  • Skordilis P, Mouzas IA, Dimoulios PD, Alexandrakis G, Moschandrea J, Kouroumalis E. Is endosonography an effective method for detection and local staging of the ampullary carcinoma? A prospective study. BMC Surg. 2002;2:1. doi:10.1186/1471-2482-2-111914153
  • Domagk D, Wessling J, Reimer P, et al. Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation. Am J Gastroenterol. 2004;99(9):1684–1689. doi:10.1111/j.1572-0241.2004.30347.x15330902
  • Ponchon T, Berger F, Chavaillon A, Bory R, Lambert R. Contribution of endoscopy to diagnosis and treatment of tumors of the ampulla of Vater. Cancer. 1989;64(1):161–167. doi:10.1002/(ISSN)1097-01422471581
  • Tse F, Barkun JS, Romagnuolo J, Friedman G, Bornstein JD, Barkun AN. Nonoperative imaging techniques in suspected biliary tract obstruction. HPB. 2006;8(6):409–425. doi:10.1080/1365182060074686718333096
  • Tierney WM, Francis IR, Eckhauser F, Elta G, Nostrant TT, Scheiman JM. The accuracy of EUS and helical CT in the assessment of vascular invasion by peripapillary malignancy. Gastrointest Endosc. 2001;53(2):182–188. doi:10.1067/mge.2001.11177611174289
  • Cannon ME, Carpenter SL, Elta GH, et al. EUS compared with CT, magnetic resonance imaging, and angiography and the influence of biliary stenting on staging accuracy of ampullary neoplasms. Gastrointest Endosc. 1999;50(1):27–33. doi:10.1016/S0016-5107(99)70340-810385718
  • Ogura T, Hara K, Hijioka S, et al. Can endoscopic ultrasound-guided fine needle aspiration offer clinical benefit for tumors of the ampulla of vater? -An initial study. Endosopic Ultrasound. 2012;1(2):84. doi:10.7178/eus.02.006
  • DeFrain C, Chang CY, Srikureja W, Nguyen PT, Gu M. Cytologic features and diagnostic pitfalls of primary ampullary tumors by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer. 2005;105(5):289–297. doi:10.1002/cncr.2130615986397
  • Grossjohann HS, Rappeport ED, Jensen C, et al. Usefulness of contrast-enhanced transabdominal ultrasound for tumor classification and tumor staging in the pancreatic head. Scand J Gastroenterol. 2010;45(7–8):917–924. doi:10.3109/0036552100370271820441527
  • Brambs H-J, Claussen CD. Pancreatic and ampullary carcinoma. Ultrasound, computed tomography, magnetic resonance imaging and angiography. Endoscopy. 1993;25(01):58–68. doi:10.1055/s-2007-10091268453928
  • Majumder S, Chubineh S, Birk J. Pancreatic cancer: an endoscopic perspective. Expert Rev Gastroenterol Hepatol. 2012;6(1):95–104. doi:10.1586/egh.11.9322149585
  • Valls C, Andía E, Sanchez A, et al. Dual-phase helical CT of pancreatic adenocarcinoma. Am J Roentgenol. 2002;178(4):821–826. doi:10.2214/ajr.178.4.178082111906855
  • Pietryga JA, Morgan DE. Imaging preoperatively for pancreatic adenocarcinoma. J Gastrointest Oncol. 2015;6(4):343–357. doi:10.3978/j.issn.2078-6891.2015.02426261722
  • Moutinho-Ribeiro P, Iglesias-Garcia J, Gaspar R, Macedo G. Early pancreatic cancer — the role of endoscopic ultrasound with or without tissue acquisition in diagnosis and staging. Dig Liver Dis. 2019;51(1):4–9. doi:10.1016/j.dld.2018.09.02730337098
  • Fusari M, Maurea S, Imbriaco M, et al. Comparison between multislice CT and MR imaging in the diagnostic evaluation of patients with pancreatic masses. Radiol Med. 2010;115(3):453–466. doi:10.1007/s11547-010-0490-720077047
  • Rao S-X, Zeng M-S, Cheng W-Z, Yao X-Z, Jin D-Y, Ji Y. Small solid tumors (< or = 2 cm) of the pancreas: relative accuracy and differentiation of CT and MR imaging. Hepatogastroenterology. 2011;58(107–108):996–1001.21830431
  • Treadwell JR, Zafar HM, Mitchell MD, Tipton K, Teitelbaum U, Jue J. Imaging tests for the diagnosis and staging of pancreatic adenocarcinoma. Pancreas. 2016;45(6):789–795. doi:10.1097/MPA.000000000000052426745859
  • Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol. 2006;4(6):717–725. doi:10.1016/j.cgh.2006.02.02016675307
  • Soriano A, Castells A, Ayuso C, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol. 2004;99(3):492–501. doi:10.1111/j.1572-0241.2004.04087.x15056091
  • Chen J, Yang R, Lu Y, Xia Y, Zhou H. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review. J Cancer Res Clin Oncol. 2012;138(9):1433–1441. doi:10.1007/s00432-012-1268-122752601
  • Jafri M, Sachdev AH, Khanna L, Gress FG. The role of real time endoscopic ultrasound guided elastography for targeting EUS-FNA of suspicious pancreatic masses: a review of the literature and a single center experience. JOP. 2016;17(5):516–524.28912670
  • Mei S, Wang M, Sun L. Contrast-enhanced EUS for differential diagnosis of pancreatic masses: a meta-analysis. Gastroenterol Res Pract. 2019;2019:1–9. doi:10.1155/2019/1670183
  • Inoue K, Ohuchida J, Ohtsuka T, et al. Severe localized stenosis and marked dilatation of the main pancreatic duct are indicators of pancreatic cancer instead of chronic pancreatitis on endoscopic retrograde balloon pancreatography. Gastrointest Endosc. 2003;58(4):510–515. doi:10.1067/S0016-5107(03)01962-X14520282
  • Kommalapati A, Tella SH, Goyal G, Ma WW, Mahipal A. Contemporary management of localized resectable pancreatic cancer. Cancers (Basel). 2018;10(1). doi:10.3390/cancers10010024
  • Ducreux M, Cuhna AS, Caramella C, et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(suppl 5):v56–v68. doi:10.1093/annonc/mdv29526314780
  • Goetze TO. Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211. doi:10.3748/wjg.v21.i43.1221126604631
  • Malvezzi M, Bertuccio P, Levi F, La, Vecchia C, Negri E. European cancer mortality predictions for the year 2014. Ann Oncol. 2014;25(8):1650–1656. doi:10.1093/annonc/mdu13824759568
  • Polkowski M, Jenssen C, Kaye P, et al. Technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline – march 2017. Endoscopy. 2017;49(10):989–1006. doi:10.1055/s-0043-11921928898917
  • Puli SR, Bechtold ML, Buxbaum JL, Eloubeidi MA. How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: a meta-analysis and systematic review. Pancreas. 2013;42(1):20–26. doi:10.1097/MPA.0b013e3182546e7923254913
  • Eloubeidi MA, Tamhane A, Varadarajulu S, Wilcox CM. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation. Gastrointest Endosc. 2006;63(4):622–629.16564863
  • Micames C, Jowell PS, White R, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc. 2003;58(5):690–695.14595302
  • Ikezawa K, Uehara H, Sakai A, et al. Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. J Gastroenterol. 2013;48(8):966–972. doi:10.1007/s00535-012-0693-x23065024
  • Wani S, Muthusamy VR, McGrath CM, et al. AGA white paper: optimizing endoscopic ultrasound-guided tissue acquisition and future directions. Clin Gastroenterol Hepatol. 2018;16(3):318–327. doi:10.1016/j.cgh.2017.10.02029074447
  • Navaneethan U, Njei B, Lourdusamy V, Konjeti R, Vargo JJ, Parsi MA. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2015;81(1):168–176.25440678
  • Burnett AS, Calvert TJ, Chokshi RJ. Sensitivity of endoscopic retrograde cholangiopancreatography standard cytology: 10-y review of the literature. J Surg Res. 2013;184(1):304–311. doi:10.1016/j.jss.2013.06.02823866788
  • Weilert F, Bhat YM, Binmoeller KF, et al. EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study. Gastrointest Endosc. 2014;80(1):97–104. doi:10.1016/j.gie.2013.12.03124559784
  • Mesrur Halefoglu A. Magnetic Resonance Cholangiopancreatography. Semin Roentgenol. 2008;43(4):282–289. doi:10.1053/j.ro.2008.06.00418774032
  • Park M-S, Kim TK, Kim KW, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology. 2004;233(1):234–240. doi:10.1148/radiol.233103144615333766
  • Rösch T, Meining A, Frühmorgen S, et al. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc. 2002;55(7):870–876. doi:10.1067/mge.2002.12420612024143
  • de Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1). Gastrointest Endosc. 2002;56(4):a128132. doi:10.1016/S0016-5107(02)70123-5
  • de Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc. 2002;56(5):a129219. doi:10.1016/S0016-5107(02)70123-5
  • Baron TH, Harewood GC, Rumalla A, et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol. 2004;2(3):214–219. doi:10.1016/S1542-3565(04)00006-015017605
  • Kipp BR, Stadheim LM, Halling SA, et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol. 2004;99(9):1675–1681. doi:10.1111/j.1572-0241.2004.30281.x15330900
  • Ponchon T, Gagnon P, Berger F, et al. Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc. 1995;42(6):565–572. doi:10.1016/S0016-5107(95)70012-98674929
  • Tummala P, Munigala S, Eloubeidi MA, Agarwal B. Patients with obstructive jaundice and biliary stricture ± mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA. J Clin Gastroenterol. 2013;47(6):532–537. doi:10.1097/MCG.0b013e3182745d9f23340062
  • Mohamadnejad M, DeWitt JM, Sherman S, et al. Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience. Gastrointest Endosc. 2011;73(1):71–78. doi:10.1016/j.gie.2010.08.05021067747
  • Hewitt MJ, MJW M, Possamai L, Dhar A, Vlavianos P, Monahan KJ. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc. 2012;75(2):319–331. doi:10.1016/j.gie.2011.08.04922248600
  • Ma MX, Jayasekeran V, Chong AK. Benign biliary strictures: prevalence, impact, and management strategies. Clin Exp Gastroenterol. 2019;12:83–92. doi:10.2147/CEG.S16501630858721
  • Chang M-C, Liang P-C, Jan S, et al. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. Pancreatology. 2014;14(5):366–372. doi:10.1016/j.pan.2014.07.01025278306
  • Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7(10):1097–1103. doi:10.1016/j.cgh.2009.04.02019410017
  • Parsa N, Khashab MA. The role of peroral cholangioscopy in evaluating indeterminate biliary strictures. Clin Endosc. 2019. doi:10.5946/ce.2019.011
  • Robles-Medranda C, Valero M, Soria-Alcivar M, et al. Reliability and accuracy of a novel classification system using peroral cholangioscopy for the diagnosis of bile duct lesions. Endoscopy. 2018;50:1059–1070.29954008
  • Kim HJ, Kim MH, Lee SK, Yoo KS, Seo DW, Min YI. Tumor vessel: a valuable cholangioscopic clue of malignant biliary stricture. Gastrointest Endosc. 2000;52(5):635–638. doi:10.1067/mge.2000.10896911060188
  • Itoi T, Osanai M, Igarashi Y, et al. Diagnostic peroral video cholangioscopy is an accurate diagnostic tool for patients with bile duct lesions. Clin Gastroenterol Hepatol. 2010;8(11):934–938. doi:10.1016/j.cgh.2010.06.02920655394
  • Mizrahi M, Khoury T, Wang Y, et al. “Apple Far from the Tree”: comparative effectiveness of fiberoptic single-operator cholangiopancreatoscopy (FSOCP) and digital SOCP (DSOCP). HPB (Oxford). 2018;20(3):285–288. doi:10.1016/j.hpb.2017.09.00229107445
  • Krishna NB, Saripalli S, Safdar R, Agarwal B. Intraductal US in evaluation of biliary strictures without a mass lesion on CT scan or magnetic resonance imaging: significance of focal wall thickening and extrinsic compression at the stricture site. Gastrointest Endosc. 2007;66(1):90–96. doi:10.1016/j.gie.2006.10.02017451708
  • Turowski F, Hügle U, Dormann A, et al. Diagnostic and therapeutic single-operator cholangiopancreatoscopy with SpyGlassDSTM: results of a multicenter retrospective cohort study. Surg Endosc. 2018;32(9):3981–3988. doi:10.1007/s00464-018-6141-029532224
  • Tamada K, Ueno N, Tomiyama T, et al. Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy. Gastrointest Endosc. 1998;47(5):341–349. doi:10.1016/S0016-5107(98)70216-09609424
  • Tabibian JH, Visrodia KH, Levy MJ, Gostout CJ. Advanced endoscopic imaging of indeterminate biliary strictures. World J Gastrointest Endosc. 2015;7(18):1268. doi:10.4253/wjge.v7.i18.126826675379
  • Meister T, Heinzow HS, Woestmeyer C, et al. Intraductal ultrasound substantiates diagnostics of bile duct strictures of uncertain etiology. World J Gastroenterol. 2013;19(6):874–881. doi:10.3748/wjg.v19.i6.87423430958
  • Baron TH, Mallery JS, Hirota WK, et al. The role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy. Gastrointest Endosc. 2003;58(5):643–649. doi:10.1016/S0016-5107(03)01994-114595292
  • Sewnath ME, Karsten TM, Prins MH, Rauws EJA, Obertop H, Gouma DJ. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg. 2002;236(1):17–27. doi:10.1097/00000658-200207000-0000512131081
  • van der Gaag NA, Rauws EAJ, CHJ VE, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010;362(2):129–137. doi:10.1056/NEJMoa090323020071702
  • Lee PJ, Podugu A, Wu D, Lee AC, Stevens T, Windsor JA. Preoperative biliary drainage in resectable pancreatic cancer: a systematic review and network meta-analysis. HPB. 2018;20(6):477–486. doi:10.1016/j.hpb.2017.12.00729526466
  • Dumonceau J-M, Tringali A, Papanikolaou I, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – updated October 2017. Endoscopy. 2018;50(09):910–930. doi:10.1055/a-0659-986430086596
  • Sauvanet A, Boher J-M, Paye F, et al. Severe jaundice increases early severe morbidity and decreases long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. J Am Coll Surg. 2015;221(2):380–389. doi:10.1016/j.jamcollsurg.2015.03.05826206638
  • Arkadopoulos N, Kyriazi MA, Papanikolaou IS, et al. Preoperative biliary drainage of severely jaundiced patients increases morbidity of pancreaticoduodenectomy: results of a case-control study. World J Surg. 2014;38(11):2967–2972. doi:10.1007/s00268-014-2669-x24952079
  • Takahashi Y, Nagino M, Nishio H, Ebata T, Igami T, Nimura Y. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg. 2010;97(12):1860–1866. doi:10.1002/bjs.v97:1220799295
  • Miura F, Sano K, Wada K, et al. Prognostic impact of type of preoperative biliary drainage in patients with distal cholangiocarcinoma. Am J Surg. 2017;214(2):256–261. doi:10.1016/j.amjsurg.2017.01.01028108067
  • Strom TJ, Klapman JB, Springett GM, et al. Comparative long-term outcomes of upfront resected pancreatic cancer after preoperative biliary drainage. Surg Endosc. 2015;29(11):3273–3281. doi:10.1007/s00464-015-4075-325631110
  • Uemura K, Murakami Y, Satoi S, et al. Impact of preoperative biliary drainage on long-term survival in resected pancreatic ductal adenocarcinoma: a multicenter observational study. Ann Surg Oncol. 2015;22(Suppl 3(S3)):S1238–S1246. doi:10.1245/s10434-015-4618-926014151
  • Crippa S, Cirocchi R, Partelli S, et al. Systematic review and meta-analysis of metal versus plastic stents for preoperative biliary drainage in resectable periampullary or pancreatic head tumors. Eur J Surg Oncol. 2016;42(9):1278–1285. doi:10.1016/j.ejso.2016.05.00127296728
  • Song TJ, Lee JH, Lee SS, et al. Metal versus plastic stents for drainage of malignant biliary obstruction before primary surgical resection. Gastrointest Endosc. 2016;84(5):814–821. doi:10.1016/j.gie.2016.04.01827109456
  • Tol JAMG, van Hooft JE, Timmer R, et al. Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer. Gut. 2016;65(12):1981–1987. doi:10.1136/gutjnl-2014-30876226306760
  • Gardner TB, Spangler CC, Byanova KL, et al. Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial. Gastrointest Endosc. 2016;84(3):460–466. doi:10.1016/j.gie.2016.02.04726972022
  • Adams MA, Anderson MA, Myles JD, Khalatbari S, Scheiman JM. Self-expanding metal stents (SEMS) provide superior outcomes compared to plastic stents for pancreatic cancer patients undergoing neoadjuvant therapy. J Gastrointest Oncol. 2012;3(4):309–313. doi:10.3978/j.issn.2078-6891.2011.05023205306
  • Tsuboi T, Sasaki T, Serikawa M, et al. Preoperative biliary drainage in cases of borderline resectable pancreatic cancer treated with neoadjuvant chemotherapy and Surgery. Gastroenterol Res Pract. 2016;2016:7968201. doi:10.1155/2016/796820126880897
  • Seo DW, Sherman S, Dua KS, et al. Covered and uncovered biliary metal stents provide similar relief of biliary obstruction during neoadjuvant therapy in pancreatic cancer: a randomized trial. Gastrointest Endosc. 2019 (Epub ahead of print). doi:10.1016/j.gie.2019.06.032
  • Cavell LK, Allen PJ, Vinoya C, et al. Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy. Am J Gastroenterol. 2013;108(7):1168–1173. doi:10.1038/ajg.2013.9323545711
  • Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc. 2002;56(6):a129868. doi:10.1016/S0016-5107(02)70356-8
  • Distler M, Kersting S, Rückert F, et al. Palliative treatment of obstructive jaundice in patients with carcinoma of the pancreatic head or distal biliary tree. Endoscopic stent placement vs. hepaticojejunostomy. JOP. 2010;11(6):568–574.21068488
  • Ho CS, Warkentin AE. Evidence-based decompression in malignant biliary obstruction. Korean J Radiol. 2012;13(Suppl 1):S56–S61. doi:10.3348/kjr.2012.13.S1.S5622563288
  • Taylor MC, McLeod RS, Langer B. Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: a meta-analysis. Liver Transpl. 2000;6(3):302–308. doi:10.1053/lv.2000.519610827230
  • Lucia Alves de Lima S, Alberto Castillo Bustamante F, Guimarães Hourneaux de Moura E, et al. Endoscopic palliative treatment versus surgical bypass in malignant low bile duct obstruction: a systematic review and meta-analysis. Int J Hepatobiliary Pancreat Dis. 2015;5:35–46.
  • Glazer ES, Hornbrook MC, Krouse RS. A meta-analysis of randomized trials: immediate stent placement vs. surgical bypass in the palliative management of malignant biliary obstruction. J Pain Symptom Manage. 2014;47(2):307–314. doi:10.1016/j.jpainsymman.2013.03.01323830531
  • Inamdar S, Slattery E, Bhalla R, Sejpal DV, Trindade AJ. Comparison of adverse events for endoscopic vs percutaneous biliary drainage in the treatment of malignant biliary tract obstruction in an inpatient national cohort. JAMA Oncol. 2016;2(1):112. doi:10.1001/jamaoncol.2015.367026513013
  • Moole H, Jaeger A, Cashman M, et al. Are self-expandable metal stents superior to plastic stents in palliating malignant distal biliary strictures? A meta-analysis and systematic review. Med J Armed Forces India. 2017;73(1):42–48. doi:10.1016/j.mjafi.2016.08.01428123244
  • Pu L Z, EGH DM, Bernardo WM, et al. Endoscopic stenting for inoperable malignant biliary obstruction: A systematic review and meta-analysis. World J Gastroenterol. 2015;21(47):13374–13385. doi:10.3748/wjg.v21.i47.1337426715823
  • Hong W, Chen X, Wu W-Z, Zhu Q, Chen X. Metal versus plastic stents for malignant biliary obstruction: an update meta-analysis. Clin Res Hepatol Gastroenterol. 2013;37(5):496–500. doi:10.1016/j.clinre.2012.12.00223333231
  • Almadi MA, Barkun A, Martel M. Plastic vs. self-expandable metal stents for palliation in malignant biliary obstruction: a series of meta-analyses. Am J Gastroenterol. 2017;112(2):260–273. doi:10.1038/ajg.2016.51227845340
  • Sawas T, Al Halabi S, Parsi MA, Vargo JJ. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc. 2015;82(2):256–267.e7. doi:10.1016/j.gie.2015.03.198025982849
  • Walter D, PGA VB, Groenen MJM, et al. Higher quality of life after metal stent placement compared with plastic stent placement for malignant extrahepatic bile duct obstruction. Eur J Gastroenterol Hepatol. 2017;29(2):231–237. doi:10.1016/S0016-5107(03)02009-127741030
  • Walter D, PGA VB, Groenen MJ, et al. Cost efficacy of metal stents for palliation of extrahepatic bile duct obstruction in a randomized controlled trial. Gastroenterology. 2015;149(1):130–138. doi:10.1053/j.gastro.2015.03.01225790742
  • Chen M-Y, Lin J-W, Zhu H-P, et al. Covered stents versus uncovered stents for unresectable malignant biliary strictures: a meta-analysis. Biomed Res Int. 2016;2016:6408067.27051667
  • Moole H, Bechtold ML, Cashman M, et al. Covered versus uncovered self-expandable metal stents for malignant biliary strictures: A meta-analysis and systematic review. Indian J Gastroenterol. 2016;35(5):323–330. doi:10.1007/s12664-016-0682-827566620
  • Li J, Li T, Sun P, et al. Covered versus uncovered self-expandable metal stents for managing malignant distal biliary obstruction: a meta-analysis. Green J, ed. PLoS One. 2016;11(2):e0149066. doi:10.1371/journal.pone.014906626859673
  • Alastal Y, Hammad TA, Khan MA, et al. Risk of post-ERCP pancreatitis after placement of covered versus uncovered self-expandable biliary metal stents: a systematic review and meta-analysis. JOP. 2015;16:452–458.
  • Saleem A, Leggett CL, Murad MH, Baron TH. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011;74(2):321–327.e1-3. doi:10.1016/j.gie.2011.03.1249
  • Almadi MA, Barkun AN, Martel M. No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11(1):27–37.e1. doi:10.1016/j.cgh.2012.10.01923103324
  • Yang Z, Wu Q, Wang F, Ye X, Qi X, Fan D. A systematic review and meta-analysis of randomized trials and prospective studies comparing covered and bare self-expandable metal stents for the treatment of malignant obstruction in the digestive tract. Int J Med Sci. 2013;10(7):825–835. doi:10.7150/ijms.596923794946
  • Tringali A, Hassan C, Rota M, Rossi M, Mutignani M, Aabakken L. Covered vs. uncovered self-expandable metal stents for malignant distal biliary strictures: a systematic review and meta-analysis. Endoscopy. 2018;50(06):631–641. doi:10.1055/s-0043-12506229342491
  • Conio M, Mangiavillano B, Caruso A, et al. Covered versus uncovered self-expandable metal stent for palliation of primary malignant extrahepatic biliary strictures: a randomized multicenter study. Gastrointest Endosc. 2018;88(2):283–291.e3. doi:10.1016/j.gie.2018.03.02929653120
  • Jang SI, Lee SJ, Jeong S, et al. Efficacy of a multiplex paclitaxel emission stent using a pluronic® mixture membrane versus a covered metal stent in malignant biliary obstruction: a prospective randomized comparative study. Gut Liver. 2017;11(4):567–573. doi:10.5009/gnl1642828335102
  • Lee YN, Moon JH, Choi HJ, et al. Effectiveness of a newly designed antireflux valve metal stent to reduce duodenobiliary reflux in patients with unresectable distal malignant biliary obstruction: a randomized, controlled pilot study (with videos). Gastrointest Endosc. 2016;83(2):404–412. doi:10.1016/j.gie.2015.08.08426385187
  • Park DH, Lee SS, Lee TH, et al. Anchoring flap versus flared end, fully covered self-expandable metal stents to prevent migration in patients with benign biliary strictures: a multicenter, prospective, comparative pilot study (with videos). Gastrointest Endosc. 2011;73(1):64–70. doi:10.1016/j.gie.2010.09.03921184871
  • Minaga K, Kitano M, Imai H, et al. Evaluation of anti-migration properties of biliary covered self-expandable metal stents. World J Gastroenterol. 2016;22(30):6917–6924. doi:10.3748/wjg.v22.i30.691727570427
  • Sharaiha RZ, Khan MA, Kamal F, et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc. 2017;85(5):904–914. doi:10.1016/j.gie.2016.12.02328063840
  • Hindryckx P, Degroote H, Tate DJ, Deprez PH. Endoscopic ultrasound-guided drainage of the biliary system: techniques, indications and future perspectives. World J Gastrointest Endosc. 2019;11(2):103–114. doi:10.4253/wjge.v11.i2.10330788029
  • Khan MA, Akbar A, Baron TH, et al. Endoscopic ultrasound-guided biliary drainage: a systematic review and meta-analysis. Dig Dis Sci. 2016;61(3):684–703. doi:10.1007/s10620-015-3933-026518417
  • Fabbri C, Luigiano C, Lisotti A, et al. Endoscopic ultrasound-guided treatments: are we getting evidence based–a systematic review. World J Gastroenterol. 2014;20(26):8424–8448. doi:10.3748/wjg.v20.i26.842425024600
  • Paik WH, Lee TH, Park DH, et al. EUS-guided biliary drainage versus ERCP for the primary palliation of malignant biliary obstruction: a multicenter randomized clinical trial. Am J Gastroenterol. 2018;113(7):987–997. doi:10.1038/s41395-018-0122-829961772
  • Bang JY, Navaneethan U, Hasan M, Hawes R, Varadarajulu S. Stent placement by EUS or ERCP for primary biliary decompression in pancreatic cancer: a randomized trial (with videos). Gastrointest Endosc. 2018;88(1):9–17. doi:10.1016/j.gie.2018.03.01229574126
  • Park JK, Woo YS, Noh DH, et al. Efficacy of EUS-guided and ERCP-guided biliary drainage for malignant biliary obstruction: prospective randomized controlled study. Gastrointest Endosc. 2018;88(2):277–282. doi:10.1016/j.gie.2018.03.01529605722
  • Nabi Z, Reddy DN. Endoscopic palliation for biliary and pancreatic malignancies: recent advances. Clin Endosc. 2019;52(3):226–234. doi:10.5946/ce.2019.00330665289
  • Dolak W, Schreiber F, Schwaighofer H, et al. Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc. 2014;28(3):854–860. doi:10.1007/s00464-013-3232-924196547
  • Yang J, Wang J, Zhou H, et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial. Endoscopy. 2018;50(8):751–760. doi:10.1055/s-0043-12487029342492
  • Sofi AA, Khan MA, Das A, et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2018;87(4):944–951.e1. doi:10.1016/j.gie.2017.10.02929108980
  • Ortner MEJ, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003;125(5):1355–1363. doi:10.1016/j.gastro.2003.07.01514598251
  • Kiesslich T, Wolkersdörfer G, Neureiter D, Salmhofer H, Berr F. Photodynamic therapy for non-resectable perihilar cholangiocarcinoma. Photochem Photobiol Sci. 2009;8(1):23–30. doi:10.1039/B813183J19247524
  • Kahaleh M, Mishra R, Shami VM, et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol. 2008;6(3):290–297. doi:10.1016/j.cgh.2007.12.00418255347
  • Cui P-J, Yao J, Zhao Y-J, Han H-Z YJ. Biliary stenting with or without sphincterotomy for malignant biliary obstruction: A meta-analysis. World J Gastroenterol. 2014;20(38):14033. doi:10.3748/wjg.v20.i38.1403325320543
  • Sofi AA, Nawras A, Alaradi OH, Alastal Y, Khan MA, Lee WM. Does endoscopic sphincterotomy reduce the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis after biliary stenting? A systematic review and meta-analysis. Dig Endosc. 2016;28(4):394–404. doi:10.1111/den.1258426636754